nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Tinidazole—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Tinidazole—Anorexia—Mycophenolic acid—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Tinidazole—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Tinidazole—Insomnia—Leflunomide—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Tinidazole—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Tinidazole—Paraesthesia—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tinidazole—Arthralgia—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tinidazole—Myalgia—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tinidazole—Dyspnoea—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Tinidazole—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Tinidazole—Discomfort—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Tinidazole—Dyspepsia—Leflunomide—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Tinidazole—Vomiting—Mometasone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Tinidazole—Feeling abnormal—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Tinidazole—Rash—Mometasone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Asthenia—Captopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Dermatitis—Mometasone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Decreased appetite—Leflunomide—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Confusional state—Lisinopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tinidazole—Headache—Mometasone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tinidazole—Insomnia—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tinidazole—Fatigue—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tinidazole—Pruritus—Captopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Tinidazole—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Tinidazole—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Tinidazole—Constipation—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Tinidazole—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tinidazole—Somnolence—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Tinidazole—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Tinidazole—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Tinidazole—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Tinidazole—Neutropenia—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Tinidazole—Body temperature increased—Azathioprine—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tinidazole—Abdominal pain—Azathioprine—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tinidazole—Skin disorder—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tinidazole—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Tinidazole—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Tinidazole—Diarrhoea—Captopril—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Tinidazole—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Tinidazole—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Tinidazole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tinidazole—Feeling abnormal—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tinidazole—Fatigue—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tinidazole—Nausea—Mometasone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tinidazole—Anorexia—Lisinopril—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tinidazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tinidazole—Ataxia—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tinidazole—Constipation—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tinidazole—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Tinidazole—Dizziness—Captopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Tinidazole—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Tinidazole—Urticaria—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tinidazole—Abdominal pain—Leflunomide—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Tinidazole—Body temperature increased—Leflunomide—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Tinidazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Tinidazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Tinidazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Tinidazole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Tinidazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Tinidazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Tinidazole—Insomnia—Lisinopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Tinidazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Tinidazole—Paraesthesia—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Tinidazole—Vomiting—Captopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Tinidazole—Dyspnoea—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Tinidazole—Rash—Captopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Tinidazole—Dermatitis—Captopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Tinidazole—Somnolence—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Tinidazole—Headache—Captopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Tinidazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Tinidazole—Dyspepsia—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Tinidazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Tinidazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Tinidazole—Decreased appetite—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tinidazole—Fatigue—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tinidazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tinidazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tinidazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tinidazole—Constipation—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tinidazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tinidazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Tinidazole—Diarrhoea—Azathioprine—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Tinidazole—Nausea—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Tinidazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Tinidazole—Asthenia—Leflunomide—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Tinidazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Tinidazole—Pruritus—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Tinidazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tinidazole—Dizziness—Azathioprine—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tinidazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tinidazole—Diarrhoea—Leflunomide—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tinidazole—Urticaria—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tinidazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tinidazole—Abdominal pain—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Tinidazole—Body temperature increased—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Tinidazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Tinidazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tinidazole—Vomiting—Azathioprine—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tinidazole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tinidazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tinidazole—Rash—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tinidazole—Dermatitis—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tinidazole—Flushing—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tinidazole—Headache—Azathioprine—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tinidazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tinidazole—Dizziness—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tinidazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Tinidazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tinidazole—Angiopathy—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tinidazole—Immune system disorder—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tinidazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Tinidazole—Sweating—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Tinidazole—Vomiting—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tinidazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tinidazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tinidazole—Rash—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tinidazole—Dermatitis—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tinidazole—Nausea—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tinidazole—Headache—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tinidazole—Malnutrition—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tinidazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Tinidazole—Asthenia—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Tinidazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Tinidazole—Pruritus—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Tinidazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Tinidazole—Rash—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tinidazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tinidazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tinidazole—Headache—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Tinidazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Tinidazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Tinidazole—Nausea—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Tinidazole—Diarrhoea—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Tinidazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Tinidazole—Angioedema—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Tinidazole—Dizziness—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tinidazole—Nausea—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tinidazole—Malaise—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tinidazole—Vertigo—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Tinidazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Tinidazole—Vomiting—Lisinopril—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Tinidazole—Rash—Lisinopril—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Tinidazole—Convulsion—Prednisone—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Tinidazole—Dermatitis—Lisinopril—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Tinidazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Tinidazole—Headache—Lisinopril—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Tinidazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Tinidazole—Arthralgia—Prednisone—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Tinidazole—Myalgia—Prednisone—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Tinidazole—Discomfort—Prednisone—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—systemic scleroderma	0.000933	0.000933	CcSEcCtD
Tinidazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Tinidazole—Nausea—Lisinopril—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Tinidazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000893	0.000893	CcSEcCtD
Tinidazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000889	0.000889	CcSEcCtD
Tinidazole—Skin disorder—Prednisone—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Tinidazole—Hyperhidrosis—Prednisone—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Tinidazole—Anorexia—Prednisone—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Tinidazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Tinidazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Tinidazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Tinidazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Tinidazole—Malaise—Methotrexate—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Tinidazole—Insomnia—Prednisone—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Tinidazole—Paraesthesia—Prednisone—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Tinidazole—Dyspepsia—Prednisone—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Tinidazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Tinidazole—Decreased appetite—Prednisone—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Tinidazole—Fatigue—Prednisone—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Tinidazole—Constipation—Prednisone—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Tinidazole—Feeling abnormal—Prednisone—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Tinidazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Tinidazole—Urticaria—Prednisone—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Tinidazole—Body temperature increased—Prednisone—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Tinidazole—Abdominal pain—Prednisone—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—systemic scleroderma	0.000688	0.000688	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Tinidazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Tinidazole—Asthenia—Prednisone—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Tinidazole—Pruritus—Prednisone—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Tinidazole—Diarrhoea—Prednisone—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Tinidazole—Dizziness—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Tinidazole—Vomiting—Prednisone—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Tinidazole—Rash—Prednisone—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Tinidazole—Dermatitis—Prednisone—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Tinidazole—Headache—Prednisone—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Tinidazole—Nausea—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Tinidazole—Rash—Methotrexate—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Tinidazole—Headache—Methotrexate—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Tinidazole—Nausea—Methotrexate—systemic scleroderma	0.000452	0.000452	CcSEcCtD
